Canada
# |
Name |
Dividend Yield |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
10.47% |
Feb. 5, 2025 | USD 2.83 | 0.39% |
|
Canada |
|
2 |
6.48% |
Feb. 5, 2025 | USD 4.81 | 1.02% |
|
Canada |
|
3 |
5.31% |
Feb. 5, 2025 | USD 6.04 | 1.20% |
|
Canada |
|
4 |
2.84% |
Feb. 5, 2025 | USD 12.79 | 1.03% |
|
Canada |
|
5 |
2.71% |
Feb. 5, 2025 | USD 6.02 | 0.73% |
|
Canada |
|
6 |
2.48% |
Feb. 5, 2025 | USD 33.75 | -1.77% |
|
Canada |
|
7 |
1.60% |
Feb. 5, 2025 | USD 49.82 | 0.09% |
|
Canada |
|
8 |
1.11% |
Feb. 5, 2025 | USD 6.79 | 1.40% |
|
Canada |
|
9 |
0.00% |
Feb. 5, 2025 | USD 22.67 | 2.32% |
|
Canada |
|
10 |
0.00% |
Feb. 5, 2025 | USD 5.03 | 6.19% |
|
Canada |
|
11 |
0.00% |
Feb. 5, 2025 | USD 5.34 | 0.41% |
|
Canada |
|
12 |
0.00% |
Feb. 5, 2025 | USD 23.71 | 1.85% |
|
Canada |
|
13 |
0.00% |
Feb. 5, 2025 | USD 6.23 | -0.19% |
|
Canada |
|
14 |
0.00% |
Feb. 5, 2025 | USD 143.69 | 8.93% |
|
Canada |
|
15 |
0.00% |
Feb. 5, 2025 | USD 2.04 | -0.20% |
|
Canada |
|
16 |
0.00% |
Feb. 5, 2025 | USD 0.15 | -5.56% |
|
Canada |
|
17 |
0.00% |
Feb. 5, 2025 | USD 28.66 | 7.56% |
|
Canada |
|
18 |
0.00% |
Feb. 5, 2025 | USD 1.14 | 2.02% |
|
Canada |
|
19 |
0.00% |
Feb. 5, 2025 | USD 2.65 | -1.93% |
|
Canada |
|
20 |
0.00% |
Feb. 5, 2025 | USD 5.88 | 1.23% |
|
Canada |
The 3D Printing company in Canada with the highest Dividend Yield is AirBoss of America Corp. (Toronto Stock Exchange: BOS.TO) at 10.47%.
The 3D Printing company in Canada with the lowest Dividend Yield is Firan Technology Group Corporation (Toronto Stock Exchange: FTG.TO) at 0.00%.
The top 10 3D Printing companies in Canada by Dividend Yield are AirBoss of America Corp., Exco Technologies Limited, Neo Performance Materials Inc., Savaria Corporation, Martinrea International Inc., Calian Group Ltd., CCL Industries Inc., Magellan Aerospace Corporation, Héroux-Devtek Inc. and POET Technologies Inc..
The bottom 10 3D Printing companies in Canada by Dividend Yield are Firan Technology Group Corporation, Medexus Pharmaceuticals Inc., Zentek Ltd., ATS Corporation, Ondine Biomedical Inc., NervGen Pharma Corp., Celestica Inc., Profound Medical Corp., CAE Inc. and 5N Plus Inc..